CytoAgents
is a Pennsylvania-based biotechnology company that develops pharmaceutical products for the treatment of COVID-19, influenza, and viral infectious diseases... Read moreCytoAgents
is a Pennsylvania-based biotechnology company that develops pharmaceutical products for the treatment of COVID-19, influenza, and viral infectious diseases... Read more
News
Sep 30, 2026
FinanzNachrichten
CytoAgents: CytoAgents, Inc.: CytoAgents Presents New Preclinical CTO1681 Data at the 2026 EADV Congress
May 20, 2026
Citybizlist
CytoAgents: CytoAgents Adds Immunology Researchers to Scientific Advisory Board as Pipeline Broadens
Dec 09, 2025
FinanzNachrichten
CytoAgents: CytoAgents, Inc.: CytoAgents to Present New CTO1681 Data at the ESMO Immuno-Oncology Congress 2025
Sep 26, 2024
Pulse2.0
CytoAgents: CytoAgents: Cytokine Release Syndrome Treatment Company Receives Third Grant From NIH
Oct 17, 2023
Business Wire
Press Release: CytoAgents : CytoAgents Announces Initiation of Patient Enrollment in Phase 1b/2a Clinical Trial to Treat Cytokine Release Syndrome in CAR T-cell Therapy
May 13, 2023
The Business Journals
CytoAgents: CytoAgents reaches FDA milestone and closes on $7 million funding round led by PCG Capital
May 11, 2023
Business Wire
Press Release: CytoAgents : CytoAgents Announces FDA Acceptance of IND Application for CTO1681 to Treat Cytokine Release Syndrome in Oncology
May 02, 2023
Citybizlist
CytoAgents: EY Announces Teresa Whalen, RPh, CEO of CytoAgents as an Entrepreneur Of The Year 2023 East Central Award Finalist
Sep 07, 2022
Business Wire
Press Release: CytoAgents : CytoAgents Announces Appointment of New Chief Medical Officer
Aug 10, 2021
The Business Journals: Pittsburgh Business Times
CytoAgents: CytoAgents adds two to board, completes fundraising round
CytoAgents Competitors
1
2
3
4
5
6
7
8
9
10